Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic mice. Issue 1 (January 2015)
- Record Type:
- Journal Article
- Title:
- Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic mice. Issue 1 (January 2015)
- Main Title:
- Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic mice
- Authors:
- Kassan, Modar
Choi, Soo‐Kyoung
Galán, Maria
Trebak, Mohamed
Belmadani, Souad
Matrougui, Khalid - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <sec id="dmrr2542-sec-0001" sec-type="section"> <title>Background</title> <p>We previously reported that enhanced nuclear factor kappa B (NFκB) activity is responsible for resistance arteries dysfunction in type 2 diabetic mice.</p> </sec> <sec id="dmrr2542-sec-0002" sec-type="section"> <title>Methods</title> <p>In this study, we aimed to determine whether augmented NFκB activity also impairs conductance artery (thoracic aorta) function in type 2 diabetic mice. We treated type 2 diabetic (db<sup>−</sup>/db<sup>−</sup>) and control (db<sup>−</sup>/db<sup>+</sup>) mice with two NFκB inhibitors (dehydroxymethylepoxyquinomicin, 6 mg/kg, twice a week and IKK‐NBD peptide, 500 µg/kg/day) for 4 weeks.</p> </sec> <sec id="dmrr2542-sec-0003" sec-type="section"> <title>Results</title> <p>As expected, the NFκB inhibition did not affect blood glucose level and body weight. Thoracic aorta vascular endothelium‐dependent relaxation (EDR), determined by the wire myograph, was impaired in diabetic mice compared with control and was significantly improved after NFκB inhibition. Interestingly, thoracic EDR was also rescued in db<sup>−</sup>/db<sup>−p50NFκB−/−</sup> and db<sup>−</sup>/db<sup>−PARP‐1−/−</sup> double knockout mice compared with db<sup>−</sup>/db<sup>−</sup> mice. Similarly, the acute <italic>in vitro</italic> down regulation of NFκB‐p65 using p65 shRNA lentiviral particles in arteries from db<sup>−</sup>/db<sup>−</sup> mice<abstract abstract-type="main"> <title>Abstract</title> <sec id="dmrr2542-sec-0001" sec-type="section"> <title>Background</title> <p>We previously reported that enhanced nuclear factor kappa B (NFκB) activity is responsible for resistance arteries dysfunction in type 2 diabetic mice.</p> </sec> <sec id="dmrr2542-sec-0002" sec-type="section"> <title>Methods</title> <p>In this study, we aimed to determine whether augmented NFκB activity also impairs conductance artery (thoracic aorta) function in type 2 diabetic mice. We treated type 2 diabetic (db<sup>−</sup>/db<sup>−</sup>) and control (db<sup>−</sup>/db<sup>+</sup>) mice with two NFκB inhibitors (dehydroxymethylepoxyquinomicin, 6 mg/kg, twice a week and IKK‐NBD peptide, 500 µg/kg/day) for 4 weeks.</p> </sec> <sec id="dmrr2542-sec-0003" sec-type="section"> <title>Results</title> <p>As expected, the NFκB inhibition did not affect blood glucose level and body weight. Thoracic aorta vascular endothelium‐dependent relaxation (EDR), determined by the wire myograph, was impaired in diabetic mice compared with control and was significantly improved after NFκB inhibition. Interestingly, thoracic EDR was also rescued in db<sup>−</sup>/db<sup>−p50NFκB−/−</sup> and db<sup>−</sup>/db<sup>−PARP‐1−/−</sup> double knockout mice compared with db<sup>−</sup>/db<sup>−</sup> mice. Similarly, the acute <italic>in vitro</italic> down regulation of NFκB‐p65 using p65 shRNA lentiviral particles in arteries from db<sup>−</sup>/db<sup>−</sup> mice also improved thoracic aorta EDR. Western blot analysis showed that the p65NFκB phosphorylation, cleaved PARP‐1 and COX‐2 expression were increased in thoracic aorta from diabetic mice, which were restored after NFκB inhibition and in db<sup>−</sup>/db<sup>−p−50NFκB−/−</sup> and db<sup>−</sup>/db<sup>−PARP‐1−/−</sup> mice.</p> </sec> <sec id="dmrr2542-sec-0004" sec-type="section"> <title>Conclusions</title> <p>The present results indicate that in male type 2 diabetic mice, the augmented NFκB activity also impairs conductance artery function through PARP‐1 and COX‐2‐dependent mechanisms. Copyright © 2014 John Wiley &amp; Sons, Ltd.</p> </sec> </abstract> … (more)
- Is Part Of:
- Diabetes/metabolism research and reviews. Volume 31:Issue 1(2015:Jan.)
- Journal:
- Diabetes/metabolism research and reviews
- Issue:
- Volume 31:Issue 1(2015:Jan.)
- Issue Display:
- Volume 31, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 31
- Issue:
- 1
- Issue Sort Value:
- 2015-0031-0001-0000
- Page Start:
- 39
- Page End:
- 49
- Publication Date:
- 2015-01
- Subjects:
- Diabetes -- Periodicals
Metabolism -- Periodicals
616.642 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/dmrr.2542 ↗
- Languages:
- English
- ISSNs:
- 1520-7552
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3579.601870
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3129.xml